Related Experiment Video

Updated: May 30, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

Different influenza vaccine formulations and adjuvants for childhood influenza vaccination

Susanna Esposito1, Nicola Principi

  • 1Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122 Milan, Italy. susanna.esposito@unimi.it

Vaccine
|August 9, 2011
PubMed

Insights

Pediatric influenza is common, affecting healthy children and those with chronic conditions. Further research is needed to identify ideal influenza vaccines for all children.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health

Background:

  • Pediatric influenza presents high attack rates, especially during pandemics.
  • Severe influenza and related complications affect both healthy children and those with chronic conditions.
  • Annual mortality rates are similar between these two pediatric groups.

Purpose of the Study:

  • To review characteristics of pediatric influenza vaccines.
  • To evaluate the prevention efficacy, safety, and tolerability of various vaccine formulations and adjuvants.
  • To identify optimal influenza vaccines for the pediatric population.

Main Methods:

  • Literature review of existing studies on pediatric influenza vaccines.
  • Analysis of data on vaccine efficacy, effectiveness, immunogenicity, and safety.
  • Comparative evaluation of different vaccine formulations and adjuvants.

Main Results:

  • Current influenza vaccines vary in characteristics, impacting their suitability for pediatric use.
  • Data on efficacy, effectiveness, immunogenicity, and safety across different formulations and adjuvants are crucial.
  • There is a need for more comprehensive data to guide vaccine selection.

Conclusions:

  • Further studies are required to collect robust efficacy, effectiveness, immunogenicity, and safety data.
  • Identifying ideal pediatric influenza vaccines will significantly benefit public health.
  • Optimized vaccines could offer substantial advantages for widespread use in children.

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...